Literature DB >> 23441240

Optimizing treatment approaches in seborrheic dermatitis.

Goldenberg Gary1.   

Abstract

Seborrheic dermatitis is a chronic, recurring, cutaneous condition that causes erythema and flaking, sometimes appearing as macules or plaques with dry white or moist oily scales. In adults, it commonly occurs in areas with high concentrations of sebaceous glands. The face and scalp are the most frequently affected areas, and involvement of multiple sites is common. Dandruff is regarded as a mild noninflammatory form of seborrheic dermatitis. There is a high incidence of seborrheic dermatitis among persons with human immunodeficiency virus infection or Parkinson's disease. The cause of seborrheic dermatitis is not well understood, but appears to be related to the composition of the sebaceous gland secretions, the proliferation of Malessezia yeasts, and the host immune response. Treatment options for nonscalp and scalp seborrheic dermatitis include topical agents and shampoos containing antifungal agents, anti-inflammatory agents, keratolytic agents, and calcineurin inhibitors. Because multiple body sites are usually involved, the physician should examine all commonly affected areas. Patients should be made aware that seborrheic dermatitis is a chronic condition that will probably recur even after successful treatment.

Entities:  

Year:  2013        PMID: 23441240      PMCID: PMC3579488     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  39 in total

1.  Seborrheic Dermatitis and Malassezia species: How Are They Related?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

Review 2.  Therapeutic update on seborrheic dermatitis.

Authors:  I Stefanaki; A Katsambas
Journal:  Skin Therapy Lett       Date:  2010-05

3.  An open-label, single-center pilot study to determine the antifungal activity of a new nonsteroidal cream (Promiseb Topical Cream) after 7 days of use in healthy volunteers.

Authors:  Leon Kircik
Journal:  Clin Dermatol       Date:  2009 Nov-Dec       Impact factor: 3.541

4.  Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study.

Authors:  J-P Ortonne; A F Nikkels; K Reich; R M Ponce Olivera; J H Lee; N Kerrouche; F Sidou; J Faergemann
Journal:  Br J Dermatol       Date:  2011-07       Impact factor: 9.302

5.  Distribution of malassezia species on the scalp in korean seborrheic dermatitis patients.

Authors:  Yang Won Lee; Hee Jin Byun; Beom Joon Kim; Dong Ha Kim; Yun Young Lim; Jin Woong Lee; Myeung Nam Kim; Donghak Kim; Young-Jin Chun; Seog Kyun Mun; Chan Woong Kim; Sung Eun Kim; Jae Sung Hwang
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

6.  Adult seborrheic dermatitis: a status report on practical topical management.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

7.  Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.

Authors:  Sophie Seite; André Rougier; Sergio Talarico
Journal:  J Cosmet Dermatol       Date:  2009-12       Impact factor: 2.696

8.  Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.

Authors:  Demet Cicek; Basak Kandi; Selma Bakar; Dilara Turgut
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

Review 9.  Facial seborrheic dermatitis: a report on current status and therapeutic horizons.

Authors:  Joseph Bikowski
Journal:  J Drugs Dermatol       Date:  2009-02       Impact factor: 2.114

Review 10.  Surface lipids as multifunctional mediators of skin responses to environmental stimuli.

Authors:  Chiara De Luca; Giuseppe Valacchi
Journal:  Mediators Inflamm       Date:  2010-10-20       Impact factor: 4.711

View more
  12 in total

1.  Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography.

Authors:  Federica Dall'Oglio; Aurora Tedeschi; Vincenzo Guardabasso; Giuseppe Micali
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

2.  Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation.

Authors:  Federica Dall'Oglio; Francesco Lacarrubba; Anna Elisa Verzì; Giuseppe Micali
Journal:  Skin Appendage Disord       Date:  2015-10-17

3.  Treatment of Seborrheic Dermatitis Using a Novel Herbal-based Cream.

Authors:  Deganit Barak-Shinar; Ruben Del Río; Lawrence J Green
Journal:  J Clin Aesthet Dermatol       Date:  2017-04

4.  Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion.

Authors:  Deganit Barak-Shinar; Lawrence J Green
Journal:  J Clin Aesthet Dermatol       Date:  2018-01-01

5.  High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis.

Authors:  Qian An; Meng Sun; Rui-Qun Qi; Li Zhang; Jin-Long Zhai; Yu-Xiao Hong; Bing Song; Hong-Duo Chen; Xing-Hua Gao
Journal:  Chin Med J (Engl)       Date:  2017-07-20       Impact factor: 2.628

6.  Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis.

Authors:  Federica Dall'Oglio; Francesco Lacarrubba; Maria Luca; Simona Boscaglia; Corinne Granger; Giuseppe Micali
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-01-24

7.  Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis.

Authors:  Ishrat Jahan; Md Rabiul Islam; Md Reazul Islam; Rubaiya Ali; S M Matiur Rahman; Zabun Nahar; Abul Hasnat; Md Saiful Islam
Journal:  Heliyon       Date:  2021-03-28

Review 8.  The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.

Authors:  Matej Skorvanek; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2016-09-08

9.  Pharmacological stimulation of Edar signaling in the adult enhances sebaceous gland size and function.

Authors:  Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Laure Willen; Terry K Smith; Kenneth Huttner; Neil Kirby; Denis J Headon; Pascal Schneider
Journal:  J Invest Dermatol       Date:  2014-09-10       Impact factor: 8.551

Review 10.  The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions.

Authors:  Samantha R Ellis; Mimi Nguyen; Alexandra R Vaughn; Manisha Notay; Waqas A Burney; Simran Sandhu; Raja K Sivamani
Journal:  Microorganisms       Date:  2019-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.